The novel oral TGF-β signaling inhibitor EW-7197 eradicates chronic myelogenous leukemia-initiating cells.
Naka K, Ishihara K, Jomen Y, Jin CHua, Kim D-H, Gu Y-K, Jeong E-S, Li S, Krause DS, Kim D-W, et al. The novel oral TGF-β signaling inhibitor EW-7197 eradicates chronic myelogenous leukemia-initiating cells. Cancer Sci. 2015.